Delivery Order SPE2DX22D0049-SPE2D824FA2CA
- Not listed
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract is for the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The award, valued at $1,558.62, is for the provision of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and its military treatment programs and facilities globally. As a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $4,231.97 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The single-award IDC, valued up to $999,999,999.00 through December 2025, serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract is for the provision of a wide range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The specific...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract requires Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D824FA2CADelivery Order
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This specific Delivery Order, valued at $10,137.49, is for the provision of pharmaceutical products and medical supplies to the DoD. The contract does not have a set-aside designation, as it was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 6/17/24 |